About
VI Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. They leverage their proprietary gene editing and delivery technologies to create transformative treatments for patients with unmet medical needs.
Technology stack
detected 2026-06-17Est. monthly stack spend~$70/mo
Emailnone
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does VI Therapeutics do?
VI Therapeutics is a biotechnology company focused on developing gene therapies for rare genetic diseases. They leverage their proprietary gene editing and delivery technologies to create transformative treatments for patients with unmet medical needs.
Where is VI Therapeutics headquartered?
VI Therapeutics is headquartered in Cambridge, United States.
When was VI Therapeutics founded?
VI Therapeutics was founded in 2017.
What industry does VI Therapeutics operate in?
VI Therapeutics operates in Life Sciences, Biotech, MedTech, HealthTech, Genomics, Drug Discovery.